WebApr 12, 2024 · Tata India Pharma & Healthcare Fund is an open-ended equity scheme that predominantly invests in equity & equity related instruments of companies from Pharma … Tata Mutual Fund Tata Asset Management Pvt. Ltd Mulla House, Ground Floor, 51, … Download the Mutual Fund Annual Reports and Half Yearly Financial Report for … WebTata India Pharma & HealthCare Fund Direct Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding Analysis, and Peers. Invest in Tata India Pharma & HealthCare Fund Online with Groww.
Tata India Pharma & HealthCare Fund Direct-Growth
WebTATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a CAGR return of 6.4% since its launch. Return for 2024 was -8%, 2024 was 19.1% and 2024 was 64.4%. ... Mutual fund investments are subject to market risks. Please read the scheme information and other related ... Web2 days ago · Meeta Shetty, fund manager at Tata Mutual Fund manages Rs 12,363 crore under six funds such as Tata Digital India, Tata Focused Equity, Tata India Pharma & … ed meds without a prescription
Historic Returns - sectoral/thematic,sectoralthematic fund …
WebMar 10, 2024 · Tata India Pharma & Heathcare Fund - IDCW Reinvestment Regular Direct Category : Sectoral/Thematic Fund House : Tata Mutual Fund NAV : ₹ 15.6039 -0.24% (as on 10th March, 2024) Crisil... Web2 days ago · Meeta Shetty, fund manager at Tata Mutual Fund manages Rs 12,363 crore under six funds such as Tata Digital India, Tata Focused Equity, Tata India Pharma & Healthcare and Tata Large & Mid Cap. She believes 2024 will be a repeat of last year as markets are expected to remain rangebound and riddled with volatility. WebGet complete details on NAV, performance, scheme objective, regular and direct plan AUMs, Returns, Minimum SIP investment amount, benchmark, fund manager performance, Tata Mutual Fund contact ... ed meds reviews